参考文献/References:
[1] 中华医学会疼痛学分会脊柱源性疼痛学组.腰椎间盘突出症诊疗中国疼痛专家共识[J].中国疼痛医学杂志,2020,26(1):2-6.
[2] AMIN RAJ M,ANDRADE NICHOLAS S,NEUMAN BRIAN J.Lumbar disc herniation[J].Current Reviews in Musculoskeletal Medicine,2017,10(4):507-516.
[3] 中华医学会骨科学分会脊柱外科学组,中华医学会骨科学分会骨科康复学组.腰椎间盘突出症诊疗指南[J].中华骨科杂志,2020,40(8):477-487.
[4] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:356-359.
[5] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:214-215.
[6] 万丽,赵晴,陈军,等.疼痛评估量表应用的中国专家共识(2020版)[J].中华疼痛学杂志,2020,16(3):177-187.
[7] FAIRBANK J.The Oswestry disability index[J].Spine(Phila Pa 1976),2000,25(22):2940-2953.
[8] 程继伟,王振林,刘伟,等,周跃.Oswestry 功能障碍指数的改良及信度和效度检验[J].中国脊柱脊髓杂志,2017,27(3):235-241.
[9] 董国菊.基于“三焦气化”理论谈中医药分期防治射血分数保留心衰的思路[J].中华中医药学刊,2023,41(4):1-3.
[10] 张天星,贺娟.三焦探源[J].北京中医药大学学报,2015,38(11):725-728.
[11] BENIAS P C,WELLS R G,SACKEY-ABOAGYE B,et al.Structure and distribution of an unrecognized interstitium in human tissues[J].Science Reports,2018,8(1):4947.
[12] FENG J T,LI H Y,HAN D,et al.A ‘green pathway' different from simple diffusion in soft matter:fast molecular transport within micro/nanoscale multiphase porous systems[J].Nano Research,2014,7(3):434-442.
[13] 孙旭云,赖永健,魏峰明,等.从“三焦气化失司”理论探讨慢性功能性便秘的治疗[J].山西中医药大学学报,2022,23(5):465-468.
[14] 王桂彬,荆琳,潘丽,等.中医治疗腰痛经验[J].中医学报,2021,36(10):2059-2062.
[15] BLUMENFELD H.临床神经解剖学:病例解析[M].李云庆,赵钢,汪昕,等译.2版.天津:天津科技翻译出版有限公司,2020:276-279.
[16] 罗思进.腰椎间盘突出症疼痛发生机制的研究进展[J].世界最新医学信息文摘,2019,19(58):38-39.
[17] DI MARTINO A,MERLINI L,FALDINI C.Autoimmunity in intervertebral disc herniation:from bench to bedside[J].Expert Opin Ther Targets,2013,17(12):1461-1470.
[18] 周岩著,邹运国点校.本草思辨录[M].北京:人民军医出版社,2015:58-59.
[19] 邹澍撰.本经疏证[M].北京:中国中医药出版社,2015:373-375.
[20] RASMUSSEN-BARR E,HELD U,GROOTEN W J,et al.Non-steroidal anti-inflammatory drugs for sciatica[J].Cochrane Database Syst Rev,2016,10(10):CD012382.
[21] ABDEL SHAHEED C,MAHER C G,BUCHBINDER R,et al.Efficacy and harms of orally,intramuscularly or intravenously administered glucocorticoids for sciatica:a systematic review and meta-analysis[J].Eur J Pain,2020,24(3):518-535.